Jazz Pharmaceuticals (JAZZ) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.97% |
| Dec 31, 2025 | 6.92% |
| Sep 30, 2025 | 9.17% |
| Jun 30, 2025 | -50.31% |
| Mar 31, 2025 | 11.63% |
| Dec 31, 2024 | 19.03% |
| Sep 30, 2024 | 14.22% |
| Jun 30, 2024 | -10.32% |
| Mar 31, 2024 | -16.59% |
| Dec 31, 2023 | -11.03% |
| Sep 30, 2023 | -1.16% |
| Jun 30, 2023 | 1.27% |
| Mar 31, 2023 | 7.20% |
| Dec 31, 2022 | -24.53% |
| Sep 30, 2022 | -18.05% |
| Jun 30, 2022 | -20.47% |
| Mar 31, 2022 | -53.89% |
| Dec 31, 2021 | -17.89% |
| Sep 30, 2021 | -20.85% |
| Jun 30, 2021 | -39.23% |
| Mar 31, 2021 | 11.74% |
| Dec 31, 2020 | 12.10% |
| Sep 30, 2020 | 13.30% |
| Jun 30, 2020 | 7.53% |
| Mar 31, 2020 | -34.68% |
| Dec 31, 2019 | -0.60% |
| Sep 30, 2019 | 33.16% |
| Jun 30, 2019 | 44.63% |
| Mar 31, 2019 | 24.10% |
| Dec 31, 2018 | 22.88% |
| Sep 30, 2018 | 13.70% |
| Jun 30, 2018 | 16.27% |
| Mar 31, 2018 | 0.80% |
| Dec 31, 2017 | 2.26% |
| Sep 30, 2017 | 12.82% |
| Jun 30, 2017 | 29.67% |
| Mar 31, 2017 | 23.07% |
| Dec 31, 2016 | 17.25% |
| Sep 30, 2016 | 14.11% |
| Jun 30, 2016 | 18.47% |
| Mar 31, 2016 | 18.09% |
| Dec 31, 2015 | 15.39% |
| Sep 30, 2015 | 13.18% |
| Jun 30, 2015 | 12.20% |